A MONEY.NET PROPERTY
Merrill Lynch Upgrades Savient Pharmaceuticals (SVNT) to Buy
12/17/2007 08:42EST by StreetInsider.com
Merrill Lynch upgrades Savient Pharmaceuticals (NASDAQ: SVNT) from Neutral to Buy.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in markets.